首页 | 本学科首页   官方微博 | 高级检索  
     

淫羊藿苷元治疗骨关节炎分子机制的网络药理学和生物信息学分析
引用本文:陈锋,章晓云,陈跃平,廖建钊,李嘉骏,宋世雷,赖渝. 淫羊藿苷元治疗骨关节炎分子机制的网络药理学和生物信息学分析[J]. 中国组织工程研究, 2021, 0(23): 3704-3710
作者姓名:陈锋  章晓云  陈跃平  廖建钊  李嘉骏  宋世雷  赖渝
作者单位:广西中医药大学附属瑞康医院创伤骨科;江西中医药大学
基金项目:国家自然科学基金资助项目(81760796,81960803);广西自然科学基金青年基金(2020GXNSFBA159053),项目负责人:章晓云;广西高校青年教师基础能力提升项目(2019KY0352);广西中医药大学2019年校级科研课题(2019QN027);广西中医药大学一流学科课题(2019XK026,2019XK029);广西崇左市科技计划项目(崇科FC2019006);2016年全国名老中医传承工作室建设项目(桂卫中医发{2016}11号);广西中医药大学岐黄工程高层次人才团队培育项目(04B1804804)。
摘    要:背景:现代药理学研究表明淫羊藿苷元具有雌激素样作用,对骨关节炎的治疗起着非常积极的作用.由于淫羊藿苷元在分子水平上治疗骨关节炎的机制尚不明确,因此利用网络药理学和生物信息学从分子水平来探究淫羊藿苷元治疗骨关节炎的作用机制,可为后期药物研发及疾病治疗提供一定理论依据.目的:基于网络药理学和生物信息学初步探讨淫羊藿苷元治疗...

关 键 词:骨关节炎    淫羊藿苷元  生物信息学  网络药理学  GEO数据库  分子对接

Molecular mechanism of anhydroicaritin in the treatment of osteoarthritis:an analysis based on network pharmacology and bioinformatics
Chen Feng,Zhang Xiaoyun,Chen Yueping,Liao Jianzhao,Li Jiajun,Song Shilei,Lai Yu. Molecular mechanism of anhydroicaritin in the treatment of osteoarthritis:an analysis based on network pharmacology and bioinformatics[J]. Chinese Journal of Tissue Engineering Research, 2021, 0(23): 3704-3710
Authors:Chen Feng  Zhang Xiaoyun  Chen Yueping  Liao Jianzhao  Li Jiajun  Song Shilei  Lai Yu
Affiliation:(Department of Orthopedics,Ruikang Hospital,Guangxi University of Chinese Medicine,Nanning 530011,Guangxi Zhuang Autonomous Region,China;Jiangxi University of Traditional Chinese Medicine,Nanchang 330004,Jiangxi Province,China)
Abstract:BACKGROUND:Modern pharmacological studies have shown that anhydroicaritin has an estrogen-like effect and plays a very positive role in the treatment of osteoarthritis.Because of anhydroicaritin's unclear mechanism underlying the treatment of osteoarthritis at the molecular level,network pharmacology and bioinformatics are introduced to explain the potential molecular mechanism of anhydroicaritin in the treatment of osteoarthritis.This can provide a theoretical basis for future drug development and disease treatment.OBJECTIVE:To preliminarily analyze the key molecular mechanism of anhydroicaritin in the treatment of osteoarthritis based on network pharmacology and bioinformatics,thereby providing new potential targets in treating osteoarthritis.METHODS:The pharmacokinetic properties of anhydroicaritin were assessed using TCMSP database.The GEO databases were searched for chips related to anhydroicaritin and osteoarthritis.The differentially expressed genes were analyzed by R language.Then protein-protein interaction networks of anhydroicaritin and osteoarthritis-related differential genes were respectively constructed to screen the hub genes of anhydroicaritin in the treatment of osteoarthritis,and molecular docking verification between anhydroicaritin and hub genes was performed.Finally,the DAVID database was used to enrich the hub genes for GO and KEGG pathway analysis.RESULTS AND CONCLUSION:The oral bioavailability and drug-likeness of anhydroicaritin were 45.41%and 0.44,respectively.The anhydroicaritin and osteoarthritis chips numbered GSE85871 and GSE1919 respectively were obtained in the GEO database,and the R language analysis screened out 152 and 1142 differential genes,respectively.The GeneMANIA database was used to construct the protein-protein interaction networks of the targets of anhydroicaritin and osteoarthritis,and 44 hub genes were merged by R language.We used molecular docking to find that anhydroicaritin and hub genes have good binding activity.The enrichment analysis of the DAVID database showed that the biological process of anhydroicaritin in the treatment of osteoarthritis included responses to calcium and metal ions,steroid hormone,and organophosphorus.The signaling pathway mainly involved included MAPK signaling pathway,osteoclast differentiation signaling pathway,PI3K-AKT signaling pathway,and interleukin-17 signaling pathway.Network pharmacology and bioinformatics could be used to effectively analyze the original gene chip data of GEO database,which could not only identify the known signal pathways related to the treatment of osteoarthritis with anhydroicaritin,but also find out some new pathways or biological processes.Anhydroicaritin is expected to be a new molecule in the treatment of osteoarthritis.
Keywords:osteoarthritis  bone  anhydroicaritin  bioinformatics  network pharmacology  GEO database  molecular docking
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号